APA (7th ed.) Citation

M, B. A., Y, Z., L, N., M, P., M, A., C, M., . . . R, F. (2026). Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.70783

Chicago Style (17th ed.) Citation

M, Barreiro-de Acosta, et al. "Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry." Alimentary Pharmacology & Therapeutics 2026. https://doi.org/10.1111/apt.70783.

MLA (9th ed.) Citation

M, Barreiro-de Acosta, et al. "Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry." Alimentary Pharmacology & Therapeutics, 2026, https://doi.org/10.1111/apt.70783.